Loading, please wait...
PLEASE NOTE: This program has already taken place. A link to the recording of the program is available below.
| This program was offered via a Zoom Webinar. |
|
Learning Objectives:
Faculty
|
| This project is funded in part by Texas Health & Human Services Texas Targeted Opioid Response. |
Date: Feb 8, 2022 12:00 PM - 01:00 PM
Registration closes on Feb 12, 2022 01:00 PM
Activity Type
- Knowledge
Support/Credits
Accreditation Statement:
University of Texas at Austin School of Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Requirements for Successful Completion: To receive contact hours for this continuing education activity, the participant must sign in, attend the entire activity, and complete and submit the evaluation form. Once successful completion has been verified, a “Certificate of Successful Completion” will be awarded for 1,0 contact hours.
Learning outcome: At the conclusion of this learning activity, the RN will verbalize intent to change practice related to knowledge gain regarding novel synthetic drugs emerging in the US drug supply and the resulting supportive actions needed by the healthcare community.
The activity’s Nurse Planner has determined that no one who has the ability to control the content of this CNE activity – planning committee members and presenters/authors/content reviewers – has a conflict of interest.
Joint Provider Statement: This CNE activity has been jointly provided by University of Texas at Austin School of Nursing collaboratively with the UT School of Pharmacy and the University of Texas Steve Hicks School of Social Work.
CNE: This activity has been approved by University of Texas at Austin School of nursing to provide 1.0 hours of nursing continuing professional development. University of Texas at Austin School of Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
CME: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine and UT College of Pharmacy. The Joe R. & Teresa Lozano Long San Antonio School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Long School of Medicine designates this material for a maximum of 1.0 AMA PRA Category 1 Credit™ .
 |
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This online activity is approved for 0.1 CEUs (1.00 contact hour) of continuing education credit. In order to receive 1.00 contact hour of CE credit, the participant must watch the webinar / video in its entirety, complete the online post-test, and complete online evaluation. |
SW/Counseling: The Office of Professional Development at The University of Texas at Austin Steve Hicks School of Social Work provides continuing education in accordance with the criteria and standards of the Texas Board of Social Workers, Licensed Professional Counselors, and Licensed Marriage and Family Therapists and Licensed Psychologist under Texas Administrative Code, Title 22, Part 34. § 781.509. Complaints about this program may be made to TSBSWE, 333 Guadalupe St., Tower 3, Room 900, Austin, TX 78701 • 512-305-7700 • 800-821-3205 • bhec.texas.gov/texas-state-board-of-social-worker-examiners/.
Registration Closed
|
TxSUS Sessions: The Real & Imagined Risks of Novel Synthetic Drugs?: This TxSUS Session will begin by addressing the prevalence of novel synthetic opioids in the illegal drug supply and dispelling common myths related to these drugs. Two experts will then debate the critical question of whether increasingly powerful opioid antagonists are needed in the current opioid risk environment. Learning Objectives
Speakers
Claire Zagorski, MSc, LP Program Coordinator of PHARM, The University of Texas at Austin College of Pharmacy
Ms. Zagorski earned a Bachelor’s Degree at The University of Texas at Austin and a Master’s Degree at The University of North Texas Health Science Center. She has practiced clinically as a paramedic in multiple treatment settings, including as a member of the Austin Harm Reduction Coalition. She founded Longhorn Stop the Bleed and is committed to supporting healthcare professionals who seek to integrate harm reduction principles in their practice.
Disclosure: Ms Zagorski has no relevant financial relationship(s) with commercial interests or conflicts of interest to disclose.
Lucas G. Hill, PharmD
Clinical Assistant Professor, The University of Texas at Austin College of Pharmacy Director and Lead Instructor, Texas Opioid Training Initiative
Dr. Hill graduated from the UMKC School of Pharmacy and completed a combined residency/fellowship in the UPMC Department of Family Medicine. He is now a clinical assistant professor at The University of Texas at Austin College of Pharmacy where he founded the PhARM Program and led implementation of Operation Naloxone. His research is focused on clinician-community collaborations to address substance use disorders through evidence-based treatment and harm reduction strategies.
Disclosure: Lucas Hill receives financial support from the Substance Abuse and Mental Health Services Administration and the Texas Health and Human Services
 |